Sensus Healthcare SRTS Insider Ownership

NASDAQ SRTS

$2.86 +0.11 (+4.00%)

At close: Oct 21, 2026 · 4:00 PM EDT

Insider Holdings by Owner

2.06Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

11.26%

▲+1.04% pp QoQ

Shares Held by Insiders

1.85Mn

filed for Sep 2026

▲+10.17% QoQ

Shares Outstanding

16.46Mn

16,462,059 shares

Direct Holdings

1.85Mn

Indirect: 1.00K

Net Shares Traded (QoQ)

+171.17K

net buying in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Over the past year, SRTS insiders bought $729,009 of stock (212.41K shares) on the open market and sold none.

By number of insiders, Sensus Healthcare saw 3 insiders buy on the open market over the past 12 months and none sell.
Among Sensus Healthcare insiders, Eric Sachetta (Director) led open-market buying over the past 12 months with $554,435 of purchases (164.17K shares); the latest was on August 31, 2026.
Away from the open market, SRTS insiders received 40K shares in stock awards over the last 12 months.
Per Business Quant data, Sensus Healthcare insiders hold 1.85Mn shares in total based on their latest Form 4 filings, up 10.17% from 1.68Mn shares at the end of Q2 2026 and up 21.09% from 1.53Mn shares at the end of Q3 2025.
Of the 1.85Mn shares held by Sensus Healthcare insiders, 1.85Mn shares (99.95%) are held directly and 1K shares (0.05%) indirectly, through trusts, partnerships, family members and other entities.
Business Quant counts 8 insiders with holdings in Sensus Healthcare stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Sensus Healthcare's three largest insider shareholders, based on their latest Form 4 filings, are Joseph C. Sardano (Chief Executive Officer, 1.22Mn shares), Eric Sachetta (Director, 294.78K shares) and Michael Sardano (President and General Counsel, 159.84K shares).
Of the shares held by SRTS insiders, 65.82% belong to Joseph C. Sardano.
Institutions owned 22.16% of SRTS shares as of Q2 2026; insiders' latest Form 4 filings account for about 11.26%, leaving roughly 66.58% with other investors, including the public.
Over the past 12 months, 3 insiders reported transactions in Sensus Healthcare stock in 15 Form 4 filings.
The insider data for SRTS reflects Form 4 filings through August 31, 2026.

Form 4 Holdings

Insiders Holding SRTS

Insiders 11

Shares held 2.06Mn

Of outstanding 12.51%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Joseph C Sardano	Chief Executive Officer	1,220,293	1,220,293	59.2%	24 Aug, 2026
2	Eric Sachetta	Director	294,784	294,784	14.3%	31 Aug, 2026
3	Michael Sardano	President And General Counsel	158,839	158,839	7.7%	16 Dec, 2025
4	Samuel O'Rear	Director	143,570	143,570	7.0%	10 May, 2023
5	Anthony Benedict Petrelli	Director	66,466	66,466	3.2%	19 Dec, 2024
6	John Heinrich	Director	59,940	59,940	2.9%	23 May, 2024
7	Javier Rampolla	Chief Financial Officer	40,745	40,745	2.0%	10 Feb, 2025
8	Megan Cornish	Director	32,000	32,000	1.6%	19 Dec, 2024
9	William H Mccall	Director	30,000	30,000	1.5%	19 Dec, 2024
10	Magdalena Martinez	Chief Operating Officer	9,759	9,759	0.5%	20 Dec, 2023
11	Nicolas Soro	Chief Operating Officer	3,546	3,546	0.2%	10 Mar, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

259 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
28 Aug, 2026	Eric Sachetta	Director	Acquired P	37,537	$3.44	$129.01K	267,480	Direct
31 Aug, 2026	Eric Sachetta	Director	Acquired P	27,304	$3.54	$96.60K	294,784	Direct
26 Aug, 2026	Eric Sachetta	Director	Acquired P	9,708	$3.29	$31.93K	219,018	Direct
27 Aug, 2026	Eric Sachetta	Director	Acquired P	10,925	$3.18	$34.75K	229,943	Direct
24 Aug, 2026	Eric Sachetta	Director	Acquired P	34,697	$3.25	$112.90K	209,310	Direct
20 Aug, 2026	Eric Sachetta	Director	Acquired P	24,000	$3.13	$75.07K	167,613	Direct
20 Aug, 2026	Joseph C Sardano	Chief Executive Officer	Acquired P	20,000	$3.02	$60.49K	1,220,293	Direct
21 Aug, 2026	Eric Sachetta	Director	Acquired P	7,000	$3.25	$22.78K	174,613	Direct
12 May, 2026	Eric Sachetta	Director	Acquired P	1,500	$3.34	$5.00K	143,613	Direct
24 Feb, 2026	Eric Sachetta	Director	Acquired P	2,000	$3.81	$7.62K	142,113	Direct
12 Dec, 2025	Michael Sardano	President And General Counsel	Acquired A	40,000	$0.00	$0	158,839	Direct
21 Nov, 2025	Eric Sachetta	Director	Acquired P	7,000	$3.93	$27.51K	140,113	Direct
13 Nov, 2025	Eric Sachetta	Director	Acquired P	2,500	$4.50	$11.25K	133,113	Direct
18 Nov, 2025	Joseph C Sardano	Chief Executive Officer	Acquired P	25,000	$4.03	$100.75K	1,200,293	Direct
11 Nov, 2025	Michael Sardano	President And General Counsel	Acquired P	1,000	$4.26	$4.26K	117,839	Direct
18 Nov, 2025	Michael Sardano	President And General Counsel	Acquired P	1,000	$3.80	$3.80K	118,839	Direct
11 Nov, 2025	Michael Sardano	President And General Counsel	Acquired P	766	$4.27	$3.27K	766	Indirect
11 Nov, 2025	Michael Sardano	President And General Counsel	Acquired P	234	$4.34	$1.02K	1,000	Indirect
11 Nov, 2025	Michael Sardano	President And General Counsel	Acquired P	1,000	$4.26	$4.26K	117,839	Direct
11 Nov, 2025	Michael Sardano	President And General Counsel	Acquired P	1,000	$4.26	$4.26K	117,839	Direct

Showing 1 to 20 of 259 transactions